New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 18, 2014
16:32 EDTAVAVAeroVironment CEO Timothy Conver enters 10b5-1 trading plan
AeroVironment announced that its CEO and chairman of the board, Timothy Conver, as Trustee of The Conver Family Trust, has established a pre-arranged stock trading plan to sell a portion of company stock held by the Trust over a specific period of time. The stock trading plan is part of a long-term strategy for asset diversification and liquidity and was adopted in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934 and AeroVironment’s policies with respect to employee stock transactions. Under its Rule 10b5-1 Plan, the Trust may sell up to 320,000 shares over a period of approximately nine months. If the Trust completes all the planned sales under its Rule 10b5-1 Plan, Conver would beneficially own approximately 2,573,660 shares of AeroVironment common stock or approximately 11.04% of the company’s current outstanding shares. The transactions under this plan will commence no earlier than September 2014 and will be disclosed publicly through Form 144 and Form 4 filings with the SEC. The Form 4 filings will also be posted on AeroVironment’s website.
News For AVAV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 8, 2014
09:10 EDTAVAVAeroVironment awarded Phase II Tern contract by DARPA valued at $19M
AeroVironment announced the Defense Advanced Research Projects Agency has selected the company and its team of industry leaders to follow its successful phase I concept design effort with a phase II preliminary design for the Tactically Exploited Reconnaissance Node, or Tern. The 12-month, $19.04M phase II effort seeks to conclude with subscale flight demonstrations prior to a planned phase III award decision.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use